Medicinal Chemistry of Small-Molecule c-Met Inhibitors: From Approved Therapies to Emerging Multitarget Anticancer Agents.

Xalkori (crizotinib) - Pfizer

Tabrecta (capmatinib) - Novartis

Tepmetko (tepotinib) - EMD Serono

Cabometyx (cabozantinib tablet) - Exelixis

Orpathys (savolitinib) - AstraZeneca, Hutchmed

http://www.ncbi.nlm.nih.gov/pubmed/42794437

Abdelgawad Fahmi; Adel S Girgis; Dalia R Aboshouk; Mariam Abdur-Rahman; Mohamed A Morsy; Mohamed S Bekheit; Siva S Panda; Sudhan Sivakumar

Sep 27, 2026